Navigation Links
MiddleBrook Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results
Date:3/4/2008

nutes early to register, download, and install any necessary audio software. The call will also be archived on the MiddleBrook website.

About MiddleBrook Pharmaceuticals:

MiddleBrook Pharmaceuticals, Inc. (Nasdaq: MBRK) is a pharmaceutical company focused on the development and commercialization of anti-infective drug products that fulfill substantial unmet medical needs in the treatment of infectious disease. The Company is developing anti-infective drugs based on its novel biological finding that bacteria exposed to antibiotics in front- loaded staccato bursts, or "pulses," are killed more efficiently and effectively than those under standard treatment regimens. Based on this finding, MiddleBrook has developed a proprietary, once-a-day pulsatile delivery technology called PULSYS(R). The Company currently markets the Keflex(R) brand of cephalexin and has received regulatory approval for MOXATAG(TM) - the first and only once-daily amoxicillin product approved for marketing in the U.S. For more on MiddleBrook, please visit http://www.middlebrookpharma.com.

About MOXATAG:

MOXATAG(TM) (amoxicillin extended-release) tablets are a once-a-day extended-release formulation of amoxicillin for oral administration consisting of three components: one immediate-release and two delayed-release. The three components are combined in a specific ratio to prolong the release of amoxicillin from MOXATAG compared to immediate-release amoxicillin. MOXATAG is intended to provide a lower treatment dose, once-daily alternative to currently approved penicillin and amoxicillin regimens for the treatment of adults and pediatric patients 12 years and older with tonsillitis and/or pharyn
'/>"/>

SOURCE MiddleBrook Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related biology technology :

1. MiddleBrook Pharmaceuticals Closes Private Placement of Common Equity Raising $21 Million
2. MiddleBrook Pharmaceuticals to Present at BIO CEO & Investor Conference 2008
3. MiddleBrook Pharmaceuticals to Announce Fourth Quarter and Full Year 2007 Financial Results on March 4, 2008
4. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
5. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
6. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
7. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
8. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
9. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
10. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
11. Poniard Pharmaceuticals Announces Participation in Upcoming Conferences

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...SHANGHAI,Nov.24/PRNewswire-Asia/--NODPharmaceutica...O)hasallowedthepatentapplicationfor,itsnano-partic...yisahighlyefficientapproachtoincorporatepeptidesor...ldeliveryofdrugs,otherwiseadministeredasinjections...edtomanymacromoleculardrugssuchasinsulin,interfero...
(Date:11/24/2009)...SHANGHAI,Nov.24/PRNewswire-Asia/--ShanghaiBiolaxya...n(SFDA)hasapprovedthe,investigationalnewdrugapplic...vativeinsulinformulationtotreatdiabetes.ThisIND,ap...lstudy. , Diabetesisadisordercharacteristicof...sofdiabetesoftenresultinseveremicro-and,macro-vasc...
(Date:11/24/2009)... The FBI recently approved the Pr...es participating in or generating DNA records for ... Madison, WI USA (PRWEB) -- The FBI recentl...m for use by laboratories participating in, or ge...ystem (NDIS). NDIS currently contains more than se...
(Date:11/24/2009)...TSXVENTURE:HTL , TORONTO,Nov.24/PRNewswire-Fi...ottoCapitalInc.,aleadingproviderofadvancedlasersys...tyclinicmarkets,todayreportedoperationalandfinanci..., ,Q32009Highlights,-Revenuewas$1.46millioncompa...6.3percentcomparedwith66.1percentinQ3,2008,-Netlos...
Breaking Biology Technology:Biolaxy Secures IND Approval for Oral Insulin 2NDIS Approval of Promega PowerPlex Kit Clears Path for More DNA Profiles to be Added to U.S. Database 2Hamilton Thorne announces third quarter results 2Hamilton Thorne announces third quarter results 3Hamilton Thorne announces third quarter results 4Hamilton Thorne announces third quarter results 5Hamilton Thorne announces third quarter results 6Hamilton Thorne announces third quarter results 7
...alia, Nov. 18 /Xinhua-PRNewswire-FirstCall/ -- Pha... had raised $11.7 million from,its Share Purchase ... of,the company were given the opportunity to purc...0 price paid by institutional investors in the,rec...icipated in the plan under which the,company will ...
...HTS, N.J., Nov. 16 Genta,Incorporated (Nasdaq: G...mination letter from the NASDAQ Stock Market stati...elisting from The NASDAQ Global,Market because the...aintain,a minimum $10,000,000 value in stockholder...)(3). The Company intends to provide a plan to,NAS...
...d., Nov. 16 Spherix Incorporated,(Nasdaq: SPEX )... $3.1,million ($0.22 per share) and $7.1 million (...nded September 30, 2007, respectively. These losse...s of 2006 due to increased,expenditures related to...,as a treatment for type 2 diabetes. The Company a...
Other Biology Technology:Pharmaxis Closes Share Purchase Plan 2Genta Receives Notice of Non-Compliance with Listing Requirement for NASDAQ Global Market 2Genta Receives Notice of Non-Compliance with Listing Requirement for NASDAQ Global Market 3Spherix Reports 3rd Quarter Earnings 2
(Date:11/24/2009)... Spanish . , The presence of increased body ...ubstances in the blood, hinders the loss and maint...ect of the University of Navarra conducted by Estb... Pharmacy. , The project, entitled "A nutrigenet...ol of body weight and inflammation," examines how ...
(Date:11/23/2009)... 23, 2009 Applied mathematicians dissected the mo..., a characteristic long leaf with a saddle-like ar...edges. The simple cause of the lily,s fan-like sha... differential growthwas revealed by using an equal...Haiyi Liang, a postdoctoral student at Harvard,s S...
(Date:11/23/2009)...0 participants gathered this week for the seventh ...conference. This year,s topic, "Synthetic Biology,...cal researchers to explore the engineering, scient...ield of synthetic biology. , Bonnie L. Bassler, ...sity and this year,s conference chair, challenged ...
Breaking Biology News(10 mins):It can be predicted the reaction obese patients will have to a diet 2The cause behind the characteristic shape of a long leaf revealed 2Synthetic biology offers new opportunities for interdisciplinary collaboration 2Better control of carbon nanotube growth promising for future electronics 14325 1Better control of carbon nanotube growth promising for future electronics 14325 2Better control of carbon nanotube growth promising for future electronics 14325 3Actress Soleil Moon Frye Cant Be Punkd 3B NFL Star Terrell Owens Upset in Final Minutes of Alzheimers Association Contest 58724 1Actress Soleil Moon Frye Cant Be Punkd 3B NFL Star Terrell Owens Upset in Final Minutes of Alzheimers Association Contest 58724 2MedicAlert Foundation to Offer 24 Hour Emergency Medical Information Services for Deaf Community Services of San Diego Inc 58721 1MedicAlert Foundation to Offer 24 Hour Emergency Medical Information Services for Deaf Community Services of San Diego Inc 58721 2MedicAlert Foundation to Offer 24 Hour Emergency Medical Information Services for Deaf Community Services of San Diego Inc 58721 3
...or food according to how stocked their nests are, ...on. , When bumblebees return to the nest from a s...ne which encourages their nest mates to also go ou... that these pheromones elicited a standard respons...s School of Biological and Chemical Sciences has s...
...ng food and water shortages in the Middle East is ...arch by an Australian climate scientist suggesting... parts of the region., Recent projections from the...raised fears that storm activity in the eastern Me...arming continues on present trends. In turn, that...
... Provide Integrated Fingerprint ...chnology, an award-winning,fingerprint biometrics ...t,Harms Software, a leading provider of management...d to begin providing M2SYS fingerprint readers and...ftware has successfully integrated M2SYS, Bio-Plug...
Other Biology News:Smells like bees' spirit 2Climate change may boost Middle East rainfall 2M2SYS Technology Innovative Fingerprint Biometrics Solution Chosen by Harms Software 2
...peptide derived from the C-terminal region catalyt...soform (PKCzeta). Specificity: Reacts with the ra...nd PKMzeta (PKCzeta II) and does not cross-react w...ve controls: mouse and rat kidney and brain homoge...
GIBCO AlbuMAX II from Invitrogen
GIBCO Dulbecco's Phosphate-Buffered Saline (D-PBS) (1X) liquid from Invitrogen
Rabbit Anti-LSD1 / BHC110 Antibody, Unconjugated from Upstate
Biology Products: